We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Healthcare spending in the U.S. totaled almost $2 trillion in 2005, or $6,697 per person, with total spending for prescription drugs in 2005 pegged at $200.7 billion, the Centers for Medicare & Medicaid Services (CMS) reported.
The FDA is rejecting the notion that it should allow unapproved prescription drugs that meet category-wide safety and efficacy standards to be approved for marketing, arguing that the risks are too great and that the approach is too expensive and time-consuming.
A bipartisan group of House and Senate lawmakers have reintroduced legislation from the last congressional session that would allow limited importation of prescription drugs.
The House has passed a bill that would extend federal funding for research on stem cells beyond the preexisting cell lines that the Bush administration approved funding for in August 2001.
A bipartisan group of House and Senate lawmakers have reintroduced legislation from the last congressional session that would allow limited importation of prescription drugs.
A joint FDA advisory committee recommendation of narrower indications for, and increased warnings on, sanofi-aventis’ antibiotic Ketek has the company taking steps to respond as a competitor may begin grabbing market share.
A new congressional report has concluded that the drug industry's increasing investment in R&D is not resulting in sufficient increases in the new drug pipeline and structural changes are necessary to fix a "stagnant" system.
The FDA may be facing increasing pressure from Capitol Hill due to its handling of Ketek, as a former agency official turned whistleblower is working with activists and a key Senate critic to take the FDA to task.